Skip to content

Evaluation of clinical safety and effectiveness when placing regular-diameter implants in the molar area

Comparative clinical research between Osstem KS SOI and Straumann Roxolid SLActive

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008903
Enrollment
22
Registered
2023-10-27
Start date
2023-08-29
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Procedure/Surgery : - target disease In patients with two missing teeth in the upper and lower single-jaw molars, one experimental group and one control group were randomly assigned to

Sponsors

Osstem Implant
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who signed the clinical trial consent form 2. Adult patients over 20 years of age 3. Patients with sufficient bone height and appropriate bone width 4. Patients whose extraction site has been completely healed (patients with a healing period of at least 2 months after extraction) 5. Patients with 2 or more missing teeth in the upper or lower molar region

Exclusion criteria

Exclusion criteria: 1. Patients whose predispositions that could intervene in clinical research results, such as periodontal disease and caries in the oral cavity, have not been completely removed before implant placement 2. Patients with Bruxism or Clenching Habit 3. Pregnant women and patients with uncontrolled systemic disease 4. Persons taking drugs for bone diseases such as osteoporosis 5. Patients with a history of radiation therapy to the face and neck 6. Mental illness or suspected mental illness 7. People who are hypersensitive to implant materials 8. Patients with a history of receiving chemotherapy such as chemotherapy for the past 1 year 9. Persons with a history of recent myocardial infarction or uncontrolled hemorrhagic disease 10. Others who are ethically or who may affect the results of a clinical trial and are inappropriate to participate in a clinical trial as determined by the clinical trial director

Design outcomes

Primary

MeasureTime frame
Evaluation of peri-implant marginal bone loss within the observation period

Secondary

MeasureTime frame
implant success rate;periodontal index;Maintenance and management of prosthesis

Countries

Korea, Republic of

Contacts

Public ContactHo-Kyung Lim

Koera University Guro Hospital

ungassi@naver.com+82-2-2626-1523

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026